Delivery Order FA558723D0001-FA558726F0040
- Not listed
- The U.S. Defense Health Agency awarded a $67,201.04 firm fixed-price delivery order to Ortho-Clinical Diagnostics (doing business as Lifescan) on August 26, 2025, for orthopedic reagents to support the 48th Medical Group located in Great Britain. This delivery order, with a completion date of June 30, 2028, is issued under a larger single-award indefinite delivery vehicle (IDV) contract valued at $2.6 million that spans from July 2023 through June 2028. The IDV, which was awarded through U.S....
- The Defense Health Agency awarded a delivery order valued at $12,830.43 to Ortho-Clinical Diagnostics (doing business as Lifescan) on July 28, 2025, for clinical chemical reagents to support the 48th Medical Group located in Great Britain, United Kingdom. This firm fixed-price delivery order, with an ultimate completion date of June 30, 2028, carries no set-aside designation and represents a task order issued against a larger single-award indefinite delivery vehicle contract valued at $2.6...
- This delivery order, awarded on June 26, 2018, to Ortho-Clinical Diagnostics (doing business as Lifescan) by the U.S. Air Force Defense Finance and Accounting Service (USAF DFAS), provides chemical reagents to support military medical operations. The contract, valued at approximately $19.9K with a firm fixed-price structure, will be performed in Great Britain, United Kingdom, and reflects the company's ongoing role as a critical supplier of diagnostic supplies to U.S. Air Force medical treatment...
- This is a firm fixed-price delivery order contract awarded by the United States Air Forces in Europe - Air Forces Africa (USAFE-AFAFRICA) to Ortho-Clinical Diagnostics, doing business as Lifescan, for the provision of reagents. The contract has a ceiling value of $24,883.44 and a completion date of September 3, 2021. Ortho-Clinical Diagnostics is a for-profit organization and manufacturer of medical diagnostic equipment and supplies, with a focus on providing clinical chemistry analyzers,...
- The U.S. Air Force Defense Finance and Accounting Service (USAF DFAS) awarded a $25,387 firm fixed-price delivery order to Ortho-Clinical Diagnostics, doing business as Lifescan, for chemical reagents on March 23, 2018. The contract was performed in Great Britain, United Kingdom, with no set-aside designation applied. Ortho-Clinical Diagnostics is a United Kingdom-based manufacturer of medical diagnostic equipment and supplies specializing in in vitro diagnostic tests, clinical chemistry...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, doing business as Lifescan, a for-profit manufacturer of medical diagnostic equipment and supplies. The $16,191.93 contract is for the provision of ortho-clinical chemical analyzer reagents in support of the 48th Medical Group's requirements at military treatment facilities in Great Britain and the United Kingdom. The contract has a period of performance through February 5, 2025....
- This is a firm fixed-price delivery order contract awarded by the Defense Health Agency, an agency within the Department of Defense, to Ortho-Clinical Diagnostics, doing business as Lifescan, a for-profit medical equipment manufacturer based in the United Kingdom. The $2,506.90 contract is for the delivery of 48 MDG ORTHO CLINICAL CHEMICAL ANALYZER REAGENTS to support the 48th Medical Group located in Great Britain. This award is part of a larger $2.6 million indefinite delivery vehicle (IDV)...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, doing business as Lifescan, a for-profit manufacturer of medical diagnostic equipment and supplies. The $2,600,000.00 contract is for the provision of urgent orthopedic clinical chemical analyzer reagents to support medical facilities in Great Britain and the United Kingdom, with a performance period through December 2, 2024. This award is issued under Ortho-Clinical Diagnostics'...
- This federal contract award to Ortho-Clinical Diagnostics, doing business as Lifescan, is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the United States Air Forces in Europe - Air Forces Africa (USAFE-AFAFRICA). The contract, valued at $7,032.36, requires the delivery of two identical clinical chemistry analyzers, along with applicable maintenance/warranty services, reagents, consumables, and necessary testing kits. The award supports the diagnostic equipment...
- Ortho-Clinical Diagnostics, operating as Lifescan, received a delivery order valued at $36,810.95 from the U.S. Air Forces Europe and Africa (USAFE-AFAFRICA) for chemical reagents. Awarded on November 24, 2017, with an ultimate completion date of November 27, 2017, this firm fixed-price contract was issued without a set-aside designation. The work was performed in Great Britain, United Kingdom, supporting Air Force medical operations in the region. As the prime contractor, Ortho-Clinical...
- FA558723D0001Indefinite Delivery Contract
- FA558723D0001-FA558726F0040Delivery Order
Ortho-Clinical Diagnostics, doing business as Lifescan, received a $42,343.17 delivery order from the Defense Health Agency on January 12, 2026, with completion targeted for June 30, 2028. This firm fixed-price contract, with no set-aside designation, represents a task order against the vendor's larger indefinite delivery vehicle contract valued at $5.2 million and awarded July 1, 2023, by United States Air Forces in Europe and Africa. The order procures orthopedic reagents and related diagnostic supplies for the 48th Medical Group located in Great Britain. Ortho-Clinical Diagnostics operates as the sole prime contractor with no identified subcontractors and performs all work at its United Kingdom facility. The underlying indefinite delivery vehicle provides the 48th Medical Group and other Air Force medical treatment facilities in the European theater with flexible access to clinical chemistry analyzers, diagnostic reagents, consumables, maintenance services, and technical support through June 30, 2028. As of mid-2025, cumulative delivery order values against this contract vehicle had exceeded $630,000 across twenty-eight task orders, reflecting the critical role of this procurement vehicle in sustaining diagnostic laboratory capabilities essential to military medical operations in Europe. The vendor's established presence as a specialized supplier of in vitro diagnostic equipment and consumables positions it as the exclusive source for these capabilities within the military healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.3k | 1/11/26 |